A phase II single-arm study of LDK378 in patients with ALK-activated (ALK plus ) non-small cell lung cancer (NSCLC) previously treated with chemotherapy and crizotinib (CRZ).
Other conference paper


Full Text

Times Cited
Web of Science1WOS source URL (as at 24/11/2020) Click here for the latest count

Other information
All Author(s) ListShaw AT, Mok T, Spigel DR, Nishio M, Felip E, Tan DSW, Garcia-Campelo MR, Gruen HJM, Dakhil SR, Schaefer ES, Farrell NJ, Blakesley RE, Weir A, Ristic M, Selvaggi G, Scagliotti G
Name of ConferenceAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Start Date of Conference31/05/2013
End Date of Conference04/06/2013
Place of ConferenceChicago
Country/Region of ConferenceUnited States of America
Journal nameJournal of Clinical Oncology
Detailed descriptionorganized by American Society of Clinical Oncology,
Year2013
Month5
Day20
Volume Number31
Issue Number15
PublisherAMER SOC CLINICAL ONCOLOGY
ISSN0732-183X
eISSN1527-7755
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology; ONCOLOGY

Last updated on 2020-25-11 at 03:08